Ninth series of the tinniwell produced for the European market
Egnach, January 25, 2024 – Following the introduction of tinniwell 2.0 with its improved features, sales are steadily increasing. The production time for individual series has been significantly reduced. It is no longer 12-18 months, but currently a maximum of one month. Product innovations can now also be implemented within series and do not require a new production cycle.
++ About Resaphene Suisse AG
Resaphene Suisse AG based in Egnach, Switzerland, is a medical technology company that was founded in 2015 and has been selling a tinnitus therapy device under the name tinniwell since 2016.
++ Contact for inquiries:
Resaphene Suisse AG
Ms. Anke Rauterkus (Chief Executive Officer)
Bahnhofplatz 5
9322 Egnach
Switzerland
T. +41 714500668